Plasma drug concentrations and virologic evaluations after stopping treatment with nonnucleoside reverse-transcriptase inhibitors in HIV type 1-infected children
Background. The optimum strategy for stopping treatment with drugs that have different half-lives in a combination regimen to minimize the risk of selecting drug-resistant viruses remains unknown. We evaluated drug concentrations in plasma, human immunodeficiency virus (HIV) load, and development of...
Saved in:
Main Authors: | Tim R. Cressey, Hannah Green, Saye Khoo, Jean Marc Treluyer, Alexandra Compagnucci, Yacine Saidi, Marc Lallemant, Diana M. Gibb, David M. Burger |
---|---|
Format: | Journal |
Published: |
2018
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=43249121119&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/60474 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Plasma drug concentrations and virologic evaluations after stopping treatment with nonnucleoside reverse-transcriptase inhibitors in HIV type 1-infected children
by: Cressey T.R., et al.
Published: (2014) -
HIV-1 drug resistance mutations in children after failure of first-line nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy
by: Puthanakit T., et al.
Published: (2014) -
HIV-1 drug resistance mutations in children after failure of first-line nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy
by: T. Puthanakit, et al.
Published: (2018) -
HIV-1 drug resistance mutations in children after failure of first-line nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy
by: Puthanakit T., et al.
Published: (2014) -
HIV-1 drug resistance mutations in children after failure of first-line nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy
by: T. Puthanakit, et al.
Published: (2018)